FOLD icon

Amicus Therapeutics
FOLD

Overview Fund Activity

225 hedge funds and large institutions have $3.3B invested in Amicus Therapeutics in 2023 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 95 increasing their positions, 58 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
225
Holders Change
-4
Holders Change %
-1.75%
% of All Funds
3.6%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.1%
New
30
Increased
95
Reduced
58
Closed
29
Calls
$4.41M
Puts
$6.36M
Net Calls
-$1.95M
Net Calls Change
-$3.56M

Top Buyers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$24.9M
2
Victory Capital Management
2
Victory Capital Management
Texas
$21.2M
3
PAMS
3
Pictet Asset Management (Switzerland)
Switzerland
$111M
4
Millennium Management
4
Millennium Management
New York
$21.5M
5
O
5
OrbiMed
New York
$13M

Top Sellers

1
RG
1
Redmile Group
California
$203M
2
Morgan Stanley
2
Morgan Stanley
New York
$183M
3
State Street
3
State Street
Massachusetts
$123M
4
Nordea Investment Management
4
Nordea Investment Management
Sweden
$0
5
Wellington Management Group
5
Wellington Management Group
Massachusetts
$83.3M
Name Holding Trade Value Shares
Change 		Shares
Change %
CG
251
Cutler Group
California
– -$2K -200 Closed
MSCM
252
McElhenny Sheffield Capital Management
Texas
– -$842 -69 Closed
Northwestern Mutual Wealth Management
253
Northwestern Mutual Wealth Management
Wisconsin
– -$244 -20 Closed
7 8 9 10
11